PET and PET/CT in Management of the Lymphomas

Donald A. Podoloff; Homer A. Macapinlac

doi:10.1016/j.rcl.2007.05.008

PET and PET/CT in Management of the Lymphomas

Donald A. Podoloff
, Homer A. Macapinlac

Nuclear Medicine

Research output: Contribution to journal › Review article › peer-review

25 Scopus citations

Abstract

Within recent years, F-18 fluorodeoxyglucose (FDG) PET has become the most important nuclear medicine and radiology imaging modality in the management of lymphoma. FDG-PET detects more disease sites and involved organs than conventional staging procedures, including CT, and has a large influence on staging. FDG-PET performed during and after therapy seems to provide considerable prognostic information. The impact on patient outcome is not clear, however, because no controlled trials have yet been conducted and follow-up periods are generally short.

Original language	English (US)
Pages (from-to)	689-696
Number of pages	8
Journal	Radiologic Clinics of North America
Volume	45
Issue number	4
DOIs	https://doi.org/10.1016/j.rcl.2007.05.008
State	Published - Jul 2007

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.rcl.2007.05.008

Cite this

@article{5d3ac80e7e1b4ee68dfb744a61236cd0,

title = "PET and PET/CT in Management of the Lymphomas",

abstract = "Within recent years, F-18 fluorodeoxyglucose (FDG) PET has become the most important nuclear medicine and radiology imaging modality in the management of lymphoma. FDG-PET detects more disease sites and involved organs than conventional staging procedures, including CT, and has a large influence on staging. FDG-PET performed during and after therapy seems to provide considerable prognostic information. The impact on patient outcome is not clear, however, because no controlled trials have yet been conducted and follow-up periods are generally short.",

author = "Podoloff, \{Donald A.\} and Macapinlac, \{Homer A.\}",

year = "2007",

month = jul,

doi = "10.1016/j.rcl.2007.05.008",

language = "English (US)",

volume = "45",

pages = "689--696",

journal = "Radiologic Clinics of North America",

issn = "0033-8389",

publisher = "W.B. Saunders",

number = "4",

}

TY - JOUR

T1 - PET and PET/CT in Management of the Lymphomas

AU - Podoloff, Donald A.

AU - Macapinlac, Homer A.

PY - 2007/7

Y1 - 2007/7

N2 - Within recent years, F-18 fluorodeoxyglucose (FDG) PET has become the most important nuclear medicine and radiology imaging modality in the management of lymphoma. FDG-PET detects more disease sites and involved organs than conventional staging procedures, including CT, and has a large influence on staging. FDG-PET performed during and after therapy seems to provide considerable prognostic information. The impact on patient outcome is not clear, however, because no controlled trials have yet been conducted and follow-up periods are generally short.

AB - Within recent years, F-18 fluorodeoxyglucose (FDG) PET has become the most important nuclear medicine and radiology imaging modality in the management of lymphoma. FDG-PET detects more disease sites and involved organs than conventional staging procedures, including CT, and has a large influence on staging. FDG-PET performed during and after therapy seems to provide considerable prognostic information. The impact on patient outcome is not clear, however, because no controlled trials have yet been conducted and follow-up periods are generally short.

UR - https://www.scopus.com/pages/publications/34547731496

UR - https://www.scopus.com/pages/publications/34547731496#tab=citedBy

U2 - 10.1016/j.rcl.2007.05.008

DO - 10.1016/j.rcl.2007.05.008

M3 - Review article

C2 - 17706533

AN - SCOPUS:34547731496

SN - 0033-8389

VL - 45

SP - 689

EP - 696

JO - Radiologic Clinics of North America

JF - Radiologic Clinics of North America

IS - 4

ER -

PET and PET/CT in Management of the Lymphomas

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this